COMPLETE GENOMICS INC Research and Development Expense
COMPLETE GENOMICS INC reported Research and Development Expense of $8.87 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2012-11-09
- COMPLETE GENOMICS INC research and development expense for the quarter ending 2012-09-30 was $8.87M, a 7.11% decline year-over-year.
- COMPLETE GENOMICS INC research and development expense for the quarter ending 2012-06-30 was $8.95M, a 11.43% increase year-over-year.
- COMPLETE GENOMICS INC research and development expense for the quarter ending 2012-03-31 was $8.69M, a 27.69% increase year-over-year.
- COMPLETE GENOMICS INC research and development expense for the quarter ending 2011-12-31 was $8.31M, a 47.32% increase year-over-year.
- COMPLETE GENOMICS INC research and development expense for fiscal 2011 was $32.69M, a 50.71% increase from fiscal 2010.
- COMPLETE GENOMICS INC research and development expense for fiscal 2010 was $21.69M, a 3.27% decline from fiscal 2009.
- COMPLETE GENOMICS INC research and development expense for fiscal 2009 was $22.42M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2012-09-30 | $8.87M 10-Q · filed 2012-11-09 | $17.81M derived: sum of 2 quarters · filed 2012-11-09 | $26.51M 10-Q · filed 2012-11-09 | $34.81M derived: sum of 4 quarters · filed 2012-11-09 |
| 2012-06-30 | $8.95M 10-Q · filed 2012-08-09 | $17.64M 10-Q · filed 2012-08-09 | $25.95M derived: sum of 3 quarters · filed 2012-08-09 | $35.49M derived: sum of 4 quarters · filed 2012-11-09 |
| 2012-03-31 | $8.69M 10-Q · filed 2012-05-09 | $17.00M derived: sum of 2 quarters · filed 2012-05-09 | $26.55M derived: sum of 3 quarters · filed 2012-11-09 | $34.58M derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-12-31 | $8.31M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $17.86M derived: sum of 2 quarters · filed 2012-11-09 | $25.88M derived: sum of 3 quarters · filed 2012-11-09 | $32.69M 10-K · filed 2012-03-09 |
| 2011-09-30 | $9.55M 10-Q · filed 2012-11-09 | $17.57M derived: sum of 2 quarters · filed 2012-11-09 | $24.38M 10-Q · filed 2012-11-09 | $30.02M derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | $8.03M 10-Q · filed 2011-08-15 | $14.84M 10-Q · filed 2012-08-09 | $20.48M derived: sum of 3 quarters · filed 2012-08-09 | $25.43M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-03-31 | $6.81M 10-Q · filed 2012-05-09 | $12.45M derived: sum of 2 quarters · filed 2012-05-09 | $17.40M derived: sum of 3 quarters · filed 2012-05-09 | $22.33M derived: sum of 4 quarters · filed 2012-05-09 |
| 2010-12-31 | $5.64M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $10.59M derived: sum of 2 quarters · filed 2012-03-09 | $15.52M derived: sum of 3 quarters · filed 2012-03-09 | $21.69M 10-K · filed 2012-03-09 |
| 2010-09-30 | $4.95M 10-Q · filed 2011-11-14 | $9.88M derived: sum of 2 quarters · filed 2011-11-14 | $16.05M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $4.93M 10-Q · filed 2011-08-15 | $11.10M 10-Q · filed 2011-08-15 | ||
| 2009-12-31 | $22.42M 10-K · filed 2012-03-09 |